KIORA PHARMACEUTICALS INC (KPRX) › Operating Cash FlowKIORA PHARMACEUTICALS INC (KPRX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$8.41M2017: -$6.47M2018: -$10.84M2019: -$8.15M2020: -$7.32M2021: -$10.68M2022: -$10.43M2023: -$9.56M2024: $8.56M2025: -$9.96M-$9.96M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$9.96M-216.4%2024$8.56M+189.6%2023-$9.56M+8.4%2022-$10.43M+2.3%2021-$10.68M-45.9%2020-$7.32M+10.3%2019-$8.15M+24.8%2018-$10.84M-67.7%2017-$6.47M+23.1%2016-$8.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share